157 related articles for article (PubMed ID: 9805978)
1. [New developments in the treatment of diabetes and hyperlipidemias].
Ducobu J
Rev Med Brux; 1998 Sep; 19(4):A379-85. PubMed ID: 9805978
[TBL] [Abstract][Full Text] [Related]
2. Statins and diabetes.
Carmena R; Betteridge DJ
Semin Vasc Med; 2004 Nov; 4(4):321-32. PubMed ID: 15861314
[TBL] [Abstract][Full Text] [Related]
3. PAR-5359, a well-balanced PPARalpha/gamma dual agonist, exhibits equivalent antidiabetic and hypolipidemic activities in vitro and in vivo.
Kim MK; Chae YN; Son MH; Kim SH; Kim JK; Moon HS; Park CS; Bae MH; Kim E; Han T; Choi HH; Shin YA; Ahn BN; Lee CH; Lim JI; Shin CY
Eur J Pharmacol; 2008 Oct; 595(1-3):119-25. PubMed ID: 18727927
[TBL] [Abstract][Full Text] [Related]
4. Promising new approaches.
Reasner CA
Diabetes Obes Metab; 1999 May; 1 Suppl 1():S41-8. PubMed ID: 11220287
[TBL] [Abstract][Full Text] [Related]
5. Regulatory issues in the approval of new drugs for diabetes mellitus, dyslipidemia, and the metabolic syndrome.
Isaacsohn JL; Troendle AJ; Orloff DG
Am J Cardiol; 2004 Jun; 93(11A):49C-52C. PubMed ID: 15178516
[No Abstract] [Full Text] [Related]
6. [Is it necessary to systematically treat diabetics with statins?].
Vergès B
Journ Annu Diabetol Hotel Dieu; 2001; ():189-95. PubMed ID: 11565462
[No Abstract] [Full Text] [Related]
7. [Favorable effects of decreasing lipids in patients with diabetes mellitus].
Gouni-Berthold I; Krone W
Dtsch Med Wochenschr; 2006 Dec; 131 Suppl 8():S252-4. PubMed ID: 17139581
[TBL] [Abstract][Full Text] [Related]
8. [Potential of combined hypoglycemic, antihypertensive, and hypolipidemic therapy in patients with diabetes mellitus and diabetic foot syndrome].
Onuchin SG; Elsukova OS; Onuchina EL
Klin Med (Mosk); 2008; 86(8):61-6. PubMed ID: 18819351
[TBL] [Abstract][Full Text] [Related]
9. Statins and fibrates in the management of diabetic dyslipidemia.
Durrington P
Diabet Med; 1997 Jul; 14(7):513-6. PubMed ID: 9223386
[No Abstract] [Full Text] [Related]
10. Fibrates and future PPARalpha agonists in the treatment of cardiovascular disease.
Staels B; Maes M; Zambon A
Nat Clin Pract Cardiovasc Med; 2008 Sep; 5(9):542-53. PubMed ID: 18628776
[TBL] [Abstract][Full Text] [Related]
11. Basic approach to managing hyperglycemia for the nonendocrinologist.
Deeg MA
Am J Cardiol; 2005 Aug; 96(4A):37E-40E. PubMed ID: 16098842
[TBL] [Abstract][Full Text] [Related]
12. Postprandial lipemia: an under-recognized atherogenic factor in patients with diabetes mellitus.
Pastromas S; Terzi AB; Tousoulis D; Koulouris S
Int J Cardiol; 2008 May; 126(1):3-12. PubMed ID: 17689745
[TBL] [Abstract][Full Text] [Related]
13. Clinical usage of hypolipidemic and antidiabetic drugs in the prevention and treatment of cancer.
Berstein LM
Cancer Lett; 2005 Jun; 224(2):203-12. PubMed ID: 15914271
[TBL] [Abstract][Full Text] [Related]
14. Statin therapy for the treatment of diabetic dyslipidemia.
Haffner SM
Diabetes Metab Res Rev; 2003; 19(4):280-7. PubMed ID: 12879405
[TBL] [Abstract][Full Text] [Related]
15. Pharmacologic treatment of type 2 diabetic dyslipidemia.
Moon YS; Kashyap ML
Pharmacotherapy; 2004 Dec; 24(12):1692-713. PubMed ID: 15585439
[TBL] [Abstract][Full Text] [Related]
16. Inflammation in diabetes mellitus: role of peroxisome proliferator-activated receptor-alpha and peroxisome proliferator-activated receptor-gamma agonists.
Libby P; Plutzky J
Am J Cardiol; 2007 Feb; 99(4A):27B-40B. PubMed ID: 17307056
[TBL] [Abstract][Full Text] [Related]
17. [Dyslipoproteinemia of diabetes: fibrates or statins?].
Moulin P
Diabetes Metab; 1999 Sep; 25(3):270-4. PubMed ID: 10499198
[No Abstract] [Full Text] [Related]
18. Muraglitazar, a novel dual (alpha/gamma) peroxisome proliferator-activated receptor activator, improves diabetes and other metabolic abnormalities and preserves beta-cell function in db/db mice.
Harrity T; Farrelly D; Tieman A; Chu C; Kunselman L; Gu L; Ponticiello R; Cap M; Qu F; Shao C; Wang W; Zhang H; Fenderson W; Chen S; Devasthale P; Jeon Y; Seethala R; Yang WP; Ren J; Zhou M; Ryono D; Biller S; Mookhtiar KA; Wetterau J; Gregg R; Cheng PT; Hariharan N
Diabetes; 2006 Jan; 55(1):240-8. PubMed ID: 16380499
[TBL] [Abstract][Full Text] [Related]
19. Plasma cell membrane glycoprotein 1 (PC-1): a marker of insulin resistance in obesity, uremia and diabetes mellitus.
Stefanović V; Antić S
Clin Lab; 2004; 50(5-6):271-8. PubMed ID: 15209435
[TBL] [Abstract][Full Text] [Related]
20. The Unitarian Hypothesis for the aetiology of diabetes mellitus.
Morrison EY; Ragoobirsingh D; Peter SA
Med Hypotheses; 2006; 67(5):1115-20. PubMed ID: 16806731
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
